Director of U.S. agency key to helming vaccine development leaves role suddenly amid coronavirus pandemic
WASHINGTON — Rick Bright, one of the nation’s leading vaccine development experts and the director of the Biomedical Advanced Research and Development Authority, is no longer leading the organization, officials told STAT.
The shakeup at the agency, known as BARDA, couldn’t come at a more inopportune time for the office, which invests in drugs, devices and other technologies that help address infectious disease outbreaks and which has been at the center of the government’s coronavirus pandemic response.
